Rigel Pharmaceuticals, Inc. (RIGL)
32.70
+0.93
(+2.93%)
USD |
NASDAQ |
Apr 17, 12:35
Rigel Pharmaceuticals Cash from Investing (Quarterly) : -25.36M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.802B |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| Amicus Therapeutics, Inc. | -6.494M |
| Nektar Therapeutics | 0.372M |
| Madrigal Pharmaceuticals, Inc. | 27.58M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 21.98M |
| Cash from Financing (Quarterly) | -4.572M |
| Free Cash Flow | 75.66M |
| Free Cash Flow Per Share (Quarterly) | 1.111 |
| Free Cash Flow to Equity (Quarterly) | 29.57M |
| Free Cash Flow to Firm (Quarterly) | 42.04M |
| Free Cash Flow Yield | 12.29% |